Related Experiment Video
Updated: Jan 29, 2026

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
Published on: May 18, 2020
DLC2 operates as a tumor suppressor gene in breast cancer via the RhoGTPase pathway
Zheng Yang1, Hanrui Chen2, Man Shu1
1Department of Pathology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong 510080, P.R. China.
Abstract:
Deleted in liver cancer 2 (DLC2) is a tumor suppressor, associated with various types of cancer. The aim of the present study was to analyze the expression of DLC2 in breast cancer, its clinical significance and its effect on breast cancer cell behavior. The expression of DLC2 was evaluated by immunohistochemistry in 131 cases of breast cancer. Associations among DLC2 expression and clinicopathological features were analyzed, and its effects on proliferation, motility, migration and invasion in DLC2-knockdown breast cancer cell lines were observed. The results indicated that DLC2 was expressed in 42.75% of breast cancer cases (56/131) and in 79.39% of adjacent normal tissues (104/131). Lower expression of DLC2 in breast cancer was associated with tumor differentiation (P<0.001), lymph node metastasis (P<0.001) and poor prognosis (P<0.001). The silencing of the DLC2 gene in human breast cancer cell indicated an increased number of cells entering S phase, and increased abilities of clone formation, cell migration and invasion. Downregulated expression of DLC2 was associated with activated Ras homolog family member A and decreased Rac family small GTPase 1, cell division cycle 42 and Rho-associated protein kinase-2 expression levels, indicating that DLC2 may serve a regulatory function in breast cancer cell proliferation and invasion via the RhoGTPase pathway. The results of the present study suggested that DLC2 serves as a suppressor gene in the development of breast cancer and may be a prognostic marker for patients with breast cancer.
Insights
Deleted in liver cancer 2 (DLC2) acts as a tumor suppressor in breast cancer. Lower DLC2 expression correlates with advanced disease and poor prognosis, impacting cell proliferation and invasion via the RhoGTPase pathway.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Deleted in liver cancer 2 (DLC2) is a known tumor suppressor implicated in various cancers.
- Understanding DLC2's role in breast cancer is crucial for developing targeted therapies and improving patient outcomes.
Purpose of the Study:
- To investigate DLC2 expression in breast cancer tissues.
- To determine the clinical significance of DLC2 expression.
- To evaluate the impact of DLC2 on breast cancer cell behavior.
Main Methods:
- Immunohistochemistry was used to assess DLC2 expression in 131 breast cancer cases and adjacent normal tissues.
- Correlation analysis was performed between DLC2 expression and clinicopathological features.
- DLC2-knockdown breast cancer cell lines were utilized to study effects on proliferation, migration, and invasion.
Main Results:
- DLC2 was expressed in 42.75% of breast cancer cases, significantly lower than in normal tissues (79.39%).
- Reduced DLC2 expression was associated with poor tumor differentiation, lymph node metastasis, and unfavorable prognosis (P<0.001).
- DLC2 gene silencing led to increased cell proliferation, migration, and invasion, linked to altered RhoGTPase pathway signaling.
Conclusions:
- DLC2 functions as a tumor suppressor in breast cancer development.
- Downregulation of DLC2 is linked to aggressive tumor characteristics and poor prognosis.
- DLC2 may serve as a valuable prognostic biomarker for breast cancer patients.
More Related Videos
07:01Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors
Published on: March 1, 2020
07:13Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
Published on: March 26, 2014
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Chromatin Position Affects Gene Expression
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...